Initially unresectable colon cancer
Showing 1 - 25 of >10,000
Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)
Recruiting
- Colorectal Cancer Metastatic
- Dexamethasone
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2023
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Colorectal Cancer, Liver Metastases Trial (Cetuximab, Bevacizumab, mFOLFOX/FOLFIRI ( Standard Chemotherapy))
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- Cetuximab
- +2 more
- (no location specified)
Aug 23, 2020
Pathological Tumor and Lymph Node Responses After Neoadjuvant
Completed
- Non Small Cell Lung Cancer
- +3 more
- Timing of drug administration
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Nov 24, 2022
Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,
Recruiting
- Gallbladder Cancer
- +2 more
- Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Relapse After Conversion Hepatectomy for Initially Unresectable
Completed
- Colorectal Cancer
- Liver Metastases
- Repeat Liver Surgery
- Non-Repeat Liver Surgery
- (no location specified)
Jul 16, 2022
Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and
Recruiting
- Unresectable Colon Cancer Peritoneal Metastases
- PMMR/Ras/BRAF Wild-type
- Serplulimab Combined With FOLFIRI and Bevacizumab
-
Huzhou, Zhejiang, ChinaChangxing County People's Hospital
Feb 14, 2023
Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- Colon Cancer Liver Metastases
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
NSCLC Trial (Sintilimab, Anlotinib)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- (no location specified)
Mar 23, 2022
Metastatic Colon Cancer, Surgery Trial in Shanghai (resection of primary tumor, XELOX, mFOLFOX6)
Recruiting
- Metastatic Colon Cancer
- Surgery
- resection of primary tumor
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 1, 2020
NSCLC, Stage III Trial in Beijing (Tislelizumab, Pemetrexed (Nonsquamous NSCLC) or Paclitaxel/Nab-paclitaxel(Squamous NSCLC),
Recruiting
- NSCLC, Stage III
- Tislelizumab
- +2 more
-
Beijing, Beijing, ChinaBeijing Tsinghua Chang Gung Hospital
Nov 4, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2
Recruiting
- Metastatic Colon Adenocarcinoma
- +20 more
- CXCR1/2 Inhibitor SX-682
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer Trial (Stereotactic Body Radiotherapy, Microwave Ablation)
Recruiting
- Colorectal Cancer Metastatic
- Liver Metastasis Colon Cancer
- Stereotactic Body Radiotherapy
- Microwave Ablation
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC
Dec 18, 2022
Biliary Tract Carcinoma, Initially Unresectable Trial in Shanghai (Combination of Gemcitabine, Oxaliplatin, Sintilimab and
Recruiting
- Biliary Tract Carcinoma
- Initially Unresectable
- Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 30, 2021
Liver Metastasis Colon Cancer Trial (Living donor liver transplantation)
Recruiting
- Liver Metastasis Colon Cancer
- Living donor liver transplantation
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 1, 2022
Metastatic or Unresectable Colon or Rectal Cancer forCOLOMATE
Recruiting
- Metastatic Colon Adenocarcinoma
- +19 more
- Genetic Testing
-
Scottsdale, Arizona
- +17 more
Mar 2, 2022
Advanced Colorectal Carcinoma, Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in United States
Recruiting
- Advanced Colorectal Carcinoma
- +26 more
- Irinotecan
- +2 more
-
Tampa, Florida
- +3 more
Jun 22, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston
Recruiting
- Metastatic Colon Adenocarcinoma
- +30 more
- Abemaciclib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2022
Advanced Colorectal Carcinoma, Liver Metastasis Colon Cancer Trial in Beijing (Fruquintinib, Hepatic Arterial Infusion
Recruiting
- Advanced Colorectal Carcinoma
- Liver Metastasis Colon Cancer
- Fruquintinib
- Hepatic Arterial Infusion Chemotherapy
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jun 1, 2022
Colorectal Cancer, Liver Metastases Trial in Belgium, Netherlands (FOLFOX/ FOLFIRI with bevacizumab, FOLFOXIRI with bevacizumab,
Recruiting
- Colorectal Cancer
- Liver Metastases
- FOLFOX/ FOLFIRI with bevacizumab
- +2 more
-
Antwerpen, Belgium
- +65 more
Mar 24, 2022
Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States
Recruiting
- Metastatic Colon Adenocarcinoma
- +7 more
- Cetuximab
- +2 more
-
Bloomington, Illinois
- +70 more
Aug 6, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Colon Cancer, Primary Tumour, Rectal Cancer Trial in Denmark, Netherlands (Surgery of the primary tumour, Systemic treatment)
Active, not recruiting
- Colon Cancer
- +2 more
- Surgery of the primary tumour
- Systemic treatment
-
Aalborg, Denmark
- +45 more
Mar 21, 2022
Colon Cancer, Rectal Cancer Trial in New York (Floxuridine, Oxaliplatin, CPT-11)
Completed
- Colon Cancer
- Rectal Cancer
- Floxuridine, Oxaliplatin, CPT-11
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 29, 2021